SI2558538T1 - Polimeri z visoko relativno molekulsko maso, ki vsebujejo dipolarni ion - Google Patents

Polimeri z visoko relativno molekulsko maso, ki vsebujejo dipolarni ion

Info

Publication number
SI2558538T1
SI2558538T1 SI201131761T SI201131761T SI2558538T1 SI 2558538 T1 SI2558538 T1 SI 2558538T1 SI 201131761 T SI201131761 T SI 201131761T SI 201131761 T SI201131761 T SI 201131761T SI 2558538 T1 SI2558538 T1 SI 2558538T1
Authority
SI
Slovenia
Prior art keywords
molecular weight
high molecular
containing polymers
zwitterion
weight zwitterion
Prior art date
Application number
SI201131761T
Other languages
English (en)
Inventor
Stephen A Charles
Victor D Perlroth
Didier G Benoit
Lane A Clizbe
Wayne To
Linda J Zadik
Jeanne M Pratt
Original Assignee
Kodiak Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kodiak Sciences Inc filed Critical Kodiak Sciences Inc
Publication of SI2558538T1 publication Critical patent/SI2558538T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
    • A61K51/065—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules conjugates with carriers being macromolecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6881—Cluster-antibody conjugates, i.e. the modifying agent consists of a plurality of antibodies covalently linked to each other or of different antigen-binding fragments covalently linked to each other
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F120/00—Homopolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F120/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F120/52—Amides or imides
    • C08F120/54—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F120/00—Homopolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F120/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F120/52—Amides or imides
    • C08F120/54—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
    • C08F120/56—Acrylamide; Methacrylamide
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F130/00—Homopolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal
    • C08F130/02—Homopolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal containing phosphorus
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2/00—Processes of polymerisation
    • C08F2/04—Polymerisation in solution
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2/00—Processes of polymerisation
    • C08F2/04—Polymerisation in solution
    • C08F2/06—Organic solvent
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2/00—Processes of polymerisation
    • C08F2/46—Polymerisation initiated by wave energy or particle radiation
    • C08F2/48—Polymerisation initiated by wave energy or particle radiation by ultraviolet or visible light
    • C08F2/50—Polymerisation initiated by wave energy or particle radiation by ultraviolet or visible light with sensitising agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F20/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F20/02—Monocarboxylic acids having less than ten carbon atoms, Derivatives thereof
    • C08F20/10—Esters
    • C08F20/12—Esters of monohydric alcohols or phenols
    • C08F20/16—Esters of monohydric alcohols or phenols of phenols or of alcohols containing two or more carbon atoms
    • C08F20/18—Esters of monohydric alcohols or phenols of phenols or of alcohols containing two or more carbon atoms with acrylic or methacrylic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F20/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F20/02—Monocarboxylic acids having less than ten carbon atoms, Derivatives thereof
    • C08F20/10—Esters
    • C08F20/26—Esters containing oxygen in addition to the carboxy oxygen
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F230/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal
    • C08F230/02—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal containing phosphorus
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F30/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal
    • C08F30/02—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal containing phosphorus
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F4/00—Polymerisation catalysts
    • C08F4/06—Metallic compounds other than hydrides and other than metallo-organic compounds; Boron halide or aluminium halide complexes with organic compounds containing oxygen
    • C08F4/10—Metallic compounds other than hydrides and other than metallo-organic compounds; Boron halide or aluminium halide complexes with organic compounds containing oxygen of alkaline earth metals, zinc, cadmium, mercury, copper or silver
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2438/00—Living radical polymerisation
    • C08F2438/01—Atom Transfer Radical Polymerization [ATRP] or reverse ATRP
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2500/00—Characteristics or properties of obtained polyolefins; Use thereof
    • C08F2500/03—Narrow molecular weight distribution, i.e. Mw/Mn < 3
SI201131761T 2010-04-15 2011-04-15 Polimeri z visoko relativno molekulsko maso, ki vsebujejo dipolarni ion SI2558538T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32441310P 2010-04-15 2010-04-15
EP11769715.1A EP2558538B1 (en) 2010-04-15 2011-04-15 High molecular weight zwitterion-containing polymers
PCT/US2011/032768 WO2011130694A2 (en) 2010-04-15 2011-04-15 High molecular weight zwitterion-containing polymers

Publications (1)

Publication Number Publication Date
SI2558538T1 true SI2558538T1 (sl) 2019-10-30

Family

ID=44799363

Family Applications (2)

Application Number Title Priority Date Filing Date
SI201131761T SI2558538T1 (sl) 2010-04-15 2011-04-15 Polimeri z visoko relativno molekulsko maso, ki vsebujejo dipolarni ion
SI201132042T SI3549963T1 (sl) 2010-04-15 2011-04-15 Polimeri z visoko molekulsko maso, ki vsebujejo zwitterion

Family Applications After (1)

Application Number Title Priority Date Filing Date
SI201132042T SI3549963T1 (sl) 2010-04-15 2011-04-15 Polimeri z visoko molekulsko maso, ki vsebujejo zwitterion

Country Status (18)

Country Link
US (4) US20140024776A1 (sl)
EP (3) EP3549963B1 (sl)
JP (5) JP2013534931A (sl)
KR (7) KR20170137938A (sl)
CN (2) CN103492489A (sl)
AU (3) AU2011239434B2 (sl)
BR (1) BR112012026118B1 (sl)
CA (1) CA2795667C (sl)
CL (1) CL2012002881A1 (sl)
CO (1) CO6630186A2 (sl)
DK (2) DK2558538T3 (sl)
ES (2) ES2742216T3 (sl)
IL (1) IL222427A0 (sl)
LT (2) LT3549963T (sl)
MX (1) MX365521B (sl)
PT (2) PT3549963T (sl)
SI (2) SI2558538T1 (sl)
WO (1) WO2011130694A2 (sl)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5528710B2 (ja) 2006-02-28 2014-06-25 オリガシス コーポレイション アクリロイルオキシエチルホスホリルコリン含有ポリマー抱合体及びその製法
US8765432B2 (en) 2009-12-18 2014-07-01 Oligasis, Llc Targeted drug phosphorylcholine polymer conjugates
AU2011239434B2 (en) * 2010-04-15 2015-04-30 Kodiak Sciences Inc. High molecular weight zwitterion-containing polymers
US9033159B1 (en) * 2011-06-07 2015-05-19 Clemson University Membrane surface modification
JP5907726B2 (ja) * 2011-12-28 2016-04-26 東邦化学工業株式会社 星型ポリマー及び原子移動ラジカル重合開始剤
WO2013109907A1 (en) * 2012-01-18 2013-07-25 University Of Kansas Drug and imaging agent delivery compositions and methods
JP6234064B2 (ja) * 2012-05-23 2017-11-22 キヤノン株式会社 重合体、前記重合体を用いた核磁気共鳴分析用または磁気共鳴イメージング用の造影剤、化合物、前記重合体を用いた核磁気共鳴分析方法および磁気共鳴イメージング方法
KR20150100706A (ko) * 2012-12-28 2015-09-02 블렌드 세라퓨틱스, 인코포레이티드 입자 내에 캡슐화된 표적화된 콘쥬게이트 및 이의 제형
EP3760639A1 (en) * 2013-09-08 2021-01-06 Kodiak Sciences Inc. Zwitterionic polymer conjugates
US9840553B2 (en) 2014-06-28 2017-12-12 Kodiak Sciences Inc. Dual PDGF/VEGF antagonists
KR20210013299A (ko) 2014-10-17 2021-02-03 코디악 사이언시스 인코포레이티드 부티릴콜린에스테라제 양성이온성 중합체 컨쥬게이트
JP6736278B2 (ja) * 2014-10-24 2020-08-05 キヤノン株式会社 重合体、前記重合体を有する光音響イメージング用造影剤
CN113876962A (zh) * 2015-04-07 2022-01-04 纪念斯隆-凯特琳癌症中心 纳米粒子免疫偶联物
CN104961853A (zh) * 2015-06-03 2015-10-07 青岛农业大学 一种新型苯乙烯微球及其制备方法
RU2744860C2 (ru) 2015-12-30 2021-03-16 Кодиак Сайенсиз Инк. Антитела и их конъюгаты
WO2017147240A1 (en) 2016-02-23 2017-08-31 Tarveda Therapeutics, Inc. Hsp90 targeted conjugates and particles and formulations thereof
CN105837741B (zh) * 2016-05-14 2018-01-02 上海大学 寡聚脯氨酸甲基丙烯酸酯/二甲氨乙基甲基丙烯酸酯共聚物及其制备方法
CN106519147B (zh) * 2016-06-08 2017-10-17 重庆博蓝鹰生物技术有限公司 微纳米材料、其表面用亲水物质共价修饰的产物及制备方法
EP3470443A4 (en) 2016-06-08 2020-02-19 Chongqing Bolanying (BLY) Biotechnology Co., Ltd., China MICRO / NANOMATERIAL, ASSOCIATED PRODUCT WITH COVALENTLY MODIFIED SURFACE USING HYDROPHILIC MATERIAL, AND MANUFACTURING METHOD
AU2018250695A1 (en) 2017-04-14 2019-11-07 Kodiak Sciences Inc. Complement factor D antagonist antibodies and conjugates thereof
TWI765080B (zh) 2017-08-13 2022-05-21 美商應用材料股份有限公司 藉由阻隔分子的交聯來增進選擇性沉積之方法
WO2019143193A1 (ko) 2018-01-19 2019-07-25 주식회사 펩진 재조합 폴리펩타이드 생산용 n-말단 융합 파트너 및 이를 이용하여 재조합 폴리 펩타이드를 생산하는방법
CN109354637A (zh) * 2018-10-13 2019-02-19 菏泽学院 聚n-异丙基丙烯酰胺油凝胶合成方法
CN109880110B (zh) * 2019-02-15 2021-07-27 华东师范大学 含聚（2-乙烯吡啶）聚肽嵌段共聚物及其制备方法和应用
CN109912790A (zh) * 2019-03-04 2019-06-21 西南交通大学 一种具有高抗凝血性的改性聚碳酸酯
CA3157509A1 (en) 2019-10-10 2021-04-15 Kodiak Sciences Inc. Methods of treating an eye disorder
US20230010871A1 (en) * 2019-12-13 2023-01-12 Folium Labs Inc. Complexes comprising a carbohydrate polymer and an active ingredient and processes for their preparation
CN110981810A (zh) * 2019-12-19 2020-04-10 东莞市维琪科技有限公司 一种脱羧肌肽的合成方法
CN111983067B (zh) * 2020-08-05 2023-03-03 河北省药品医疗器械检验研究院(河北省化妆品检验研究中心) 一种注射用拉氧头孢钠聚合物的检测方法及在线鉴定的检测方法
US20230365750A1 (en) * 2020-09-25 2023-11-16 Nof Corporation Method for producing maleimide polyethylene glycol lipid
JP7417227B2 (ja) 2021-01-28 2024-01-18 国立研究開発法人物質・材料研究機構 空気電池正極用の炭素多孔体の製造方法

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5162218A (en) 1988-11-18 1992-11-10 The Regents Of The University Of California Conjugated polypeptides and methods for their preparation
GB9301702D0 (en) 1993-01-28 1993-03-17 Biocompatibles Ltd New materials
GB9301701D0 (en) 1993-01-28 1993-03-17 Biocompatibles Ltd New zwitterionic materials
US6156884A (en) 1996-08-05 2000-12-05 Prolinx, Inc. Bifunctional boronic compound complexing reagents and complexes
KR20010031190A (ko) 1997-10-16 2001-04-16 아비게닉스, 인코포레이티드 조류 트랜스제네시스용 매그넘-특이적 프로모터를함유하는 벡터
JP4162284B2 (ja) * 1998-02-04 2008-10-08 日油株式会社 洗浄剤組成物
US6781030B1 (en) 1998-11-02 2004-08-24 Trustee Of Tufts College, Ballou Hall Methods for cloning mammals using telophase oocytes
ATE438724T1 (de) 1998-12-21 2009-08-15 Genencor Int Chemisch modifizierte enzymen mit mehrfachgeladenen varianten
FR2794459B1 (fr) * 1999-05-19 2004-09-03 Atofina Polyalcoxyamines issues de nitroxydes beta-substitues
CA2385528C (en) 1999-10-01 2013-12-10 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
EP1325046B1 (en) * 2000-10-06 2007-06-27 Biocompatibles UK Limited Zwitterionic polymers
US6780428B2 (en) * 2001-06-08 2004-08-24 Labopharm, Inc. Unimolecular polymeric micelles with an ionizable inner core
JP2003064132A (ja) * 2001-08-28 2003-03-05 Nof Corp 重合体、製造方法および乳化・分散剤
WO2003033521A1 (en) 2001-10-16 2003-04-24 Massachusetts Institute Of Technology Inppressor trna system in mammalian cells for the introduction of unnatural amino acids in polypeptides.
EP2226316B1 (en) 2002-05-30 2016-01-13 The Scripps Research Institute Copper-catalysed ligation of azides and acetylenes
EP1545613B9 (en) 2002-07-31 2012-01-25 Seattle Genetics, Inc. Auristatin conjugates and their use for treating cancer, an autoimmune disease or an infectious disease
GB0301014D0 (en) * 2003-01-16 2003-02-19 Biocompatibles Ltd Conjugation reactions
US7820753B2 (en) * 2003-02-05 2010-10-26 Biocompatibles Uk Limited Block copolymers
CN1208358C (zh) * 2003-07-31 2005-06-29 上海交通大学 含多羟基官能团多臂星状超支化聚合物刷及其制备方法
EP1718667B1 (en) 2004-02-23 2013-01-09 Genentech, Inc. Heterocyclic self-immolative linkers and conjugates
JP4727938B2 (ja) * 2004-02-24 2011-07-20 泰彦 岩崎 リビングラジカル重合開始基を持つポリリン酸の製造方法および用途
JP4727941B2 (ja) * 2004-03-12 2011-07-20 泰彦 岩崎 生分解性重合体の製造方法および用途
AU2005232371B2 (en) 2004-03-23 2010-10-14 Complex Biosystems Gmbh Polymeric prodrug with a self-immolative linker
PL1824988T3 (pl) 2004-11-12 2018-01-31 Bayer Healthcare Llc Ukierunkowana na miejsce modyfikacja czynnika VIII
DE102006009004A1 (de) * 2006-02-23 2007-09-06 Sustech Gmbh & Co. Kg Multifunktionelle sternförmige Präpolymere, deren Herstellung und Verwendung
JP5528710B2 (ja) * 2006-02-28 2014-06-25 オリガシス コーポレイション アクリロイルオキシエチルホスホリルコリン含有ポリマー抱合体及びその製法
JP2007263935A (ja) * 2006-03-30 2007-10-11 Canon Inc 磁性マーカー及びその製造方法
WO2007148230A2 (en) * 2006-04-14 2007-12-27 Interface Biologics Incorporated Grafted polymers and uses thereof
EP2395099A3 (en) 2006-05-02 2012-05-16 Allozyne, Inc. Amino acid substituted molecules
EP2230264B1 (en) * 2006-06-29 2019-10-09 Life Technologies AS Particles containing multi-block polymers
CN102614528B (zh) 2006-08-18 2014-02-26 箭头研究公司 用于体内递送多核苷酸的多缀合物
JP5111016B2 (ja) * 2006-11-01 2012-12-26 三井化学株式会社 表面親水性ポリオレフィン成形体およびその製造方法
WO2008064058A2 (en) * 2006-11-21 2008-05-29 Abbott Laboratories Use of a terpolymer of tetrafluoroethylene, hexafluoropropylene, and vinylidene fluoride in drug eluting coatings
EP2118150B1 (en) * 2007-02-14 2015-09-23 Biocompatibles UK Limited Derivatisation of biological molecules
CN101053681B (zh) * 2007-04-10 2010-05-19 天津大学 用于血管栓塞材料的温敏性MPC-b-NIPAM二嵌段星型共聚物及制备方法和应用
JP2009042617A (ja) * 2007-08-10 2009-02-26 Canon Inc 静電荷像現像用トナー及びその製造方法
US7943370B2 (en) * 2007-08-23 2011-05-17 Canon Kabushiki Kaisha Structure, target substance detection element and target substance detection kit
NO2842575T3 (sl) 2008-03-18 2018-02-24
US8236319B2 (en) 2008-04-30 2012-08-07 Immunogen, Inc. Cross-linkers and their uses
EP2282720B1 (en) * 2008-05-15 2013-09-11 Biocompatibles Uk Ltd. Intracellular antibody delivery
JP5344420B2 (ja) * 2008-05-15 2013-11-20 独立行政法人国立循環器病研究センター 遺伝子導入剤及びその製造方法並びに核酸複合体
WO2010126552A1 (en) 2009-04-30 2010-11-04 Immunogen, Inc. Potent cell-binding agent drug conjugates
CN101575402B (zh) * 2009-05-31 2012-06-27 中国科学院化学研究所 一种多臂星型聚合物及其制备方法
DK2260873T3 (da) * 2009-06-08 2019-09-16 Biocompatibles Uk Ltd Pcylering af proteiner
KR101159674B1 (ko) * 2009-11-16 2012-06-25 주식회사 케이씨씨 모노실란의 정제방법
US8765432B2 (en) * 2009-12-18 2014-07-01 Oligasis, Llc Targeted drug phosphorylcholine polymer conjugates
AU2011239434B2 (en) * 2010-04-15 2015-04-30 Kodiak Sciences Inc. High molecular weight zwitterion-containing polymers

Also Published As

Publication number Publication date
JP2016040371A (ja) 2016-03-24
AU2017201930B2 (en) 2019-04-18
CN106432557A (zh) 2017-02-22
JP7217245B2 (ja) 2023-02-02
JP2022165998A (ja) 2022-11-01
EP3549963B1 (en) 2022-01-12
KR20230113857A (ko) 2023-08-01
WO2011130694A3 (en) 2014-03-20
ES2905690T3 (es) 2022-04-11
US20200171179A1 (en) 2020-06-04
US20170143841A1 (en) 2017-05-25
JP2013534931A (ja) 2013-09-09
EP2558538A4 (en) 2016-08-17
MX2012011876A (es) 2012-11-30
JP6754749B2 (ja) 2020-09-16
AU2015207898A1 (en) 2015-08-20
PT3549963T (pt) 2022-02-02
PT2558538T (pt) 2019-10-10
KR20210084676A (ko) 2021-07-07
CA2795667C (en) 2018-09-04
ES2742216T3 (es) 2020-02-13
KR102416359B1 (ko) 2022-07-01
LT2558538T (lt) 2019-09-25
MX365521B (es) 2019-06-06
KR20130097636A (ko) 2013-09-03
KR20180130008A (ko) 2018-12-05
AU2011239434B2 (en) 2015-04-30
BR112012026118B1 (pt) 2021-01-05
KR20170137938A (ko) 2017-12-13
CO6630186A2 (es) 2013-03-01
DK3549963T3 (da) 2022-02-14
DK2558538T3 (da) 2019-08-05
EP3549963A3 (en) 2019-12-25
CA2795667A1 (en) 2011-10-20
AU2017201930A1 (en) 2017-04-13
KR20200067958A (ko) 2020-06-12
US20140024776A1 (en) 2014-01-23
LT3549963T (lt) 2022-03-10
KR102562175B1 (ko) 2023-07-31
KR20220039860A (ko) 2022-03-29
EP4029510A1 (en) 2022-07-20
EP2558538A2 (en) 2013-02-20
IL222427A0 (en) 2012-12-31
CN103492489A (zh) 2014-01-01
EP2558538B1 (en) 2019-07-03
JP2020189967A (ja) 2020-11-26
AU2011239434A1 (en) 2012-11-08
CL2012002881A1 (es) 2013-07-05
WO2011130694A2 (en) 2011-10-20
EP3549963A2 (en) 2019-10-09
JP2018087330A (ja) 2018-06-07
JP6568748B2 (ja) 2019-08-28
US20210402015A1 (en) 2021-12-30
SI3549963T1 (sl) 2022-04-29

Similar Documents

Publication Publication Date Title
IL222427A0 (en) High molecular weight zwitterion-containing polymers
GB2494607B (en) Semiconducting polymers
EP2629760A4 (en) THERAPEUTIC NANOPARTICLES CONTAINING COPOLYMERS OF HIGH MOLECULAR WEIGHT
HK1223635A1 (zh) 光活性聚合物材料
HK1184480A1 (zh) 共軛聚合物
ZA201205562B (en) Dye polymers
PL2930205T5 (pl) Polimer mający multimodalny rozkład mas cząsteczkowych
GB201215227D0 (en) Semiconducting polymers
EP2555741A4 (en) SPRAYABLE COMPOSITION COMPRISING A POLYMER FILLED WITH HIGH MOLECULAR WEIGHT
HUE048869T2 (hu) Polimer szilán-tartalmú karbinol-végcsoporttal
EP2739682A4 (en) LOW EQUIVALENT WEIGHT POLYMERS
GB201003970D0 (en) Polymer synthesis
EP2617746A4 (en) NEW COPOLYMER
ZA201208161B (en) Molecular sieve ssz-81
ZA201304292B (en) Polymer systems
PL2439234T3 (pl) Kompozycja polimerowa
EP2589614A4 (en) NEW COPOLYMER
GB0915682D0 (en) Branched high molecular weight addition copolymers
GB201111056D0 (en) Novel polymers
GB201012273D0 (en) Polymer compositon
GB201105482D0 (en) Polymers
GB201007905D0 (en) Functional conjugated polymers
HUE037952T2 (hu) Trialkilszililoxi végcsoportokat tartalmazó polimer
EP2804633A4 (en) ARGININE-PREPARED BIODEGRADABLE POLYMERS WITH HIGH MOLECULAR WEIGHT
SG10201503404TA (en) Polymerization process